Charles River Laboratories International, Inc. (CRL)
298.58
+3.39
(+1.15%)
USD |
NYSE |
Aug 24, 16:00
298.74
+0.16
(+0.05%)
Pre-Market: 20:00
Charles River Laboratories International Total Liabilities (Quarterly) : 4.644B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.644B |
| March 31, 2026 | 4.742B |
| December 31, 2025 | 3.924B |
| September 30, 2025 | 4.063B |
| June 30, 2025 | 4.161B |
| March 31, 2025 | 4.341B |
| December 31, 2024 | 4.020B |
| September 30, 2024 | 4.176B |
| June 30, 2024 | 4.175B |
| March 31, 2024 | 4.449B |
| December 31, 2023 | 4.536B |
| September 30, 2023 | 4.256B |
| June 30, 2023 | 4.472B |
| March 31, 2023 | 4.543B |
| December 31, 2022 | 4.579B |
| September 30, 2022 | 4.711B |
| June 30, 2022 | 4.836B |
| March 31, 2022 | 4.404B |
| December 31, 2021 | 4.432B |
| September 30, 2021 | 4.594B |
| June 30, 2021 | 4.366B |
| March 31, 2021 | 3.593B |
| December 31, 2020 | 3.347B |
| September 30, 2020 | 3.288B |
| June 30, 2020 | 3.460B |
| Date | Value |
|---|---|
| March 31, 2020 | 3.522B |
| December 31, 2019 | 3.026B |
| September 30, 2019 | 3.018B |
| June 30, 2019 | 3.147B |
| March 31, 2019 | 2.505B |
| December 31, 2018 | 2.518B |
| September 30, 2018 | 2.523B |
| June 30, 2018 | 2.664B |
| March 31, 2018 | 1.841B |
| December 31, 2017 | 1.866B |
| September 30, 2017 | 1.825B |
| June 30, 2017 | 1.792B |
| March 31, 2017 | 1.803B |
| December 31, 2016 | 1.858B |
| September 30, 2016 | 1.802B |
| June 30, 2016 | 1.901B |
| March 31, 2016 | 1.291B |
| December 31, 2015 | 1.303B |
| September 30, 2015 | 1.297B |
| June 30, 2015 | 1.150B |
| March 31, 2015 | 1.150B |
| December 31, 2014 | 1.181B |
| September 30, 2014 | 1.144B |
| June 30, 2014 | 1.165B |
| March 31, 2014 | 931.50M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| IQVIA Holdings, Inc. | 23.58B |
| Medpace Holdings, Inc. | 1.623B |
| Fortrea Holdings, Inc. | 2.191B |
| Avantor, Inc. | 5.966B |
| Champions Oncology, Inc. | 22.92M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.532B |
| Shareholders Equity (Quarterly) | 2.840B |
| Debt to Equity Ratio | 1.069 |
| Current Ratio | 1.348 |
| Net Debt Paydown Yield | -0.08% |